Frontiers | Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How? | Immunology
Antigen Delivery to Plasmacytoid Dendritic Cells via BST2 Induces Protective T Cell-Mediated Immunity | The Journal of Immunology
Plasmacytoid dendritic cells control T-cell response to chronic viral infection | PNAS
Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection | Scientific Reports
Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection | Scientific Reports
Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation | The Journal of
Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity | Nature Communications
Antigen-Presentation Properties of Plasmacytoid Dendritic Cells: Immunity
Antigen Delivery to Plasmacytoid Dendritic Cells via BST2 Induces Protective T Cell-Mediated Immunity | The Journal of Immunology
Dendritic Cells
The multifaceted biology of plasmacytoid dendritic cells | Nature Reviews Immunology
PLOS Pathogens: STING-Licensed Macrophages Prime Type I IFN Production by Plasmacytoid Dendritic Cells in the Bone Marrow during Severe Plasmodium yoelii Malaria
Dendritic Cells Developmental Lineage Pathway
Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation | The Journal of
Antibodies | Free Full-Text | Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo
A Guide to Dendritic Cell Markers | Biocompare: The Buyer's Guide for Life Scientists